Quantitative easing

Yield makes a comeback

Two months into 2012, Mitul Kotecha assesses the modest healing process that appears to have taken hold in currency markets after a period of marked risk aversion, and explains why yield is becoming a key factor influencing investor appetite

Tracking the effects of QE on cable

Commonwealth Bank of Australia, Wells Fargo and Standard Chartered take top position for GBP/USD forecasts through accurate analysis of the effects of central bank policies on the two currencies

The renminbi's road to success

The renminbi is on the up, but is it climbing fast enough? Farah Khalique talks to currency strategists and a global head of FX structuring about the performance of the currency and future trends

Sterling: hamstrung by the latest round of QE?

With the announcement from the Bank of England on October 6 of a further round of quantitative easing, the consensus view of contributors to FX Week’s currency forecast index is that cable will remain around 1.55 for the next three months, despite being…

View from a global head of FX

Tim Carrington, global head of FX at Royal Bank of Scotland, talks to Farah Khalique about the exceptionally poor liquidity in FX markets in recent weeks and why he remains bearish on the US dollar but bullish on sterling and the yen

Reality check on CAD and AUD assumptions

Jeremy Stretch, head of FX strategy at CIBC in London, asks whether the Canadian or the Australian dollar is a better buy in an environment in which both appear attractive alternatives to struggling traditional currencies

Parker down in October

The Parker FX Index reported a loss at -0.12% in October, as markets were marked by a depreciating US dollar, with the DXY Index declining to -1.85%.

Signs of dollar weakness

Divyang Shah, strategist at Thomson Reuters IFR Markets, winner of the FX Week Best Bank award for FX strategy and research, shares his views on broad-based dollar weakness

You need to sign in to use this feature. If you don’t have a FX Markets account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: